Video
ProDigest recreates the gastrointestinal tract to assess the mechanism of action of components such as prebiotics, probiotics or drugs.
We discussed the role of the microbiome in HPV-positive head and neck cancer patients with Marc Oliva Bernal (Institut Català d’Oncologia, Spain).
Does the microbiota contribute to breast cancer development? We asked this question to Sridhar Mani, from the Albert Einstein College of Medicine in New York (USA).
Rémy Burcelin explains how understanding the link between gut microbiota, metabolic syndrome and cancer could be useful from a therapeutic point of view.
CosmosID detects and identifies microorganisms of all kinds using next-generation sequencing. We discussed CosmosID's approach with Arne Materna, the company's VP Product.
Radiotherapy against prostate cancer may cause serious intestinal side effects. We discussed the impact of the local microbiota with Miguel Reis Ferreira.
The existence of a tumor microbiota have a lot of implications. We discussed this topic with Sandrine Miller-Montgomery (UC San Diego).
The modulation of the microbiota impacts on the efficacy of the new anti-PD-1 cancer therapies. We discuss it with Giorgio Trinchieri (NIH, USA).
Probiota 2020: interview with Nathan Gray, Senior Editor at Nutraingredients.
The Microbiome Movement was founded in 2016 by Alexander Puttick and his colleagues from Hanson Wade in London. Now Alexander Puttick's invitation is to participate in upcoming events.
